As cancer treatment evolves with the advent of new immunotherapies, it is crucial to accurately identify which patients will respond to these treatments. The tumor microenvironment (TME) has been shown to be a key factor in determining therapeutic responses across various cancer types.
Join Akoya Biosciences for a webinar on the PhenoImager Solution, which revolutionizes spatial phenotyping for translational and clinical research with a focus on speed, scale, accuracy, and reproducibility.
During this webinar, Dr. Cecilia Lindskog, research group leader and associate professor from Uppsala University, describes how scRNA-seq, spatial proteomics, and machine learning algorithms can be used to generate high-resolution spatio-temporal maps of human tissues.
Developing a Spatio-Temporal Single-Cell Type Map of Adult Human Tissues Read More »
Endometrial cancer is the most common gynecologic malignancy diagnosed in western countries, with most cases diagnosed as low-grade, early-stage disease.
Bladder cancer (BC) is the 10th most common cancer world-wide with an estimated 570,000+ people being diagnosed in 2020.
The emergence of new immunotherapies as the first line of treatment for cancer, necessitates the development of clinically useful biomarkers to select responders that will be critical for the advancement of such treatments.
The emergence of new immunotherapies as the first line of treatment for cancer, necessitates the development of clinically useful biomarkers to select responders that will be critical for the advancement of such treatments.
PhenoCode Signature Virtual Launch Event Read More »
In this webinar, we discuss how an innovative multiomic solution can redefine the way we think about spatial phenotyping, the infinite possibilities these techniques provide for spatial biology research.
Developing Spatial Signatures as Biomarkers for Predicting Response to Immunotherapy Read More »
Breakthrough spatial biology applications such as spatial phenotyping (whole-slide imaging at a single-cell/sub-cellular resolution with tissue context) span the discovery-to-clinical continuum.
Spatial PhenoTyping in the Era of Immunotherapy Read More »
High-grade gliomas are a group of malignant brain tumors with a dismal prognosis and exceptionally high intra- and intertumoral heterogeneity.
